Bluebird Financial Statements From 2010 to 2024

BLUE Stock  USD 0.36  0.01  2.86%   
Bluebird Bio financial statements provide useful quarterly and yearly information to potential Bluebird bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bluebird Bio financial statements helps investors assess Bluebird Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bluebird Bio's valuation are summarized below:
Gross Profit
-247.2 M
Market Capitalization
68.1 M
Enterprise Value Revenue
6.8868
Revenue
54.9 M
Earnings Share
(1.80)
There are over one hundred nineteen available fundamental signals for Bluebird bio, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of Bluebird Bio's prevailing performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road.

Bluebird Bio Total Revenue

41.4 Million

Check Bluebird Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluebird Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8 M, Interest Expense of 31.6 M or Selling General Administrative of 126.8 M, as well as many indicators such as Price To Sales Ratio of 4.88, Dividend Yield of 0.0 or PTB Ratio of 0.46. Bluebird financial statements analysis is a perfect complement when working with Bluebird Bio Valuation or Volatility modules.
  
Check out the analysis of Bluebird Bio Correlation against competitors.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

Bluebird Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.1 B619.2 M900.3 M
Slightly volatile
Other Current Liabilities8.6 MM42.2 M
Slightly volatile
Total Current Liabilities114.3 M200.1 M97.9 M
Slightly volatile
Other Liabilities101.6 K107 K23.5 M
Very volatile
Property Plant And Equipment Net174.1 M267 M148.9 M
Slightly volatile
Current Deferred Revenue1.3 M1.4 M10.4 M
Very volatile
Accounts Payable15.1 M18.5 M13 M
Slightly volatile
Cash287 M221.8 M247 M
Slightly volatile
Non Current Assets Total352.4 M337.5 M301.2 M
Slightly volatile
Other Assets33.2 M59.9 M30.4 M
Slightly volatile
Cash And Short Term Investments198.6 M209 M602.1 M
Pretty Stable
Common Stock Total Equity431.4 K817.6 K418.4 K
Slightly volatile
Common Stock Shares Outstanding202.4 M192.8 M62.3 M
Slightly volatile
Liabilities And Stockholders Equity1.1 B638.1 M903.6 M
Slightly volatile
Non Current Liabilities Total161.3 M224.5 M143.4 M
Slightly volatile
Other Current Assets9.4 M9.9 M46 M
Pretty Stable
Other Stockholder Equity5.1 B4.8 B2.3 B
Slightly volatile
Total Liabilities275.6 M424.6 M241.3 M
Slightly volatile
Property Plant And Equipment Gross181.3 M308.9 M154.9 M
Slightly volatile
Total Current Assets267.6 M281.7 M570.3 M
Pretty Stable
Short Term Debt106.6 M101.5 M31.4 M
Slightly volatile
Common StockM954.5 K473.5 K
Slightly volatile
Property Plant Equipment351.8 M335.1 M140.6 M
Slightly volatile
Net Tangible Assets203 M213.7 M647.9 M
Pretty Stable
Net Receivables23.3 M22.2 M8.1 M
Slightly volatile
Capital Surpluse2.6 B4.7 B2.2 B
Slightly volatile
Deferred Long Term Liabilities38 M28.2 M31.6 M
Slightly volatile
Non Current Liabilities Other100.5 K105.8 K35.4 M
Pretty Stable
Short and Long Term Debt Total181.8 M323.6 M150.7 M
Slightly volatile
Long Term Debt Total134.8 M176.3 M114.9 M
Slightly volatile
Short and Long Term Debt123.9 M179.2 M115.3 M
Slightly volatile
Capital Lease Obligations208.4 M330.3 M163 M
Slightly volatile
Net Invested Capital184.8 M194.5 M1.2 B
Slightly volatile
Net Working Capital77.5 M81.6 M896.3 M
Slightly volatile
Capital Stock955.5 K1.9 M702.9 K
Slightly volatile

Bluebird Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And AmortizationM5.8 M6.7 M
Slightly volatile
Selling General Administrative126.8 M165.5 M108.7 M
Slightly volatile
Total Revenue41.4 M29.5 M35.4 M
Slightly volatile
Other Operating Expenses385.4 M328.6 M329 M
Slightly volatile
Research Development260.7 M167.7 M223.6 M
Slightly volatile
Cost Of Revenue36.1 M33.5 M42.6 M
Pretty Stable
Total Operating Expenses373.9 M273.8 M320.6 M
Slightly volatile
Interest Income7.6 M9.9 M6.3 M
Slightly volatile
Reconciled Depreciation19 M28.5 M15.6 M
Slightly volatile
Extraordinary Items84.8 M95.4 M103.9 M
Slightly volatile
Non Recurring20.6 M23.2 M25.3 M
Slightly volatile

Bluebird Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation18.5 M19.4 M52.2 M
Slightly volatile
Begin Period Cash Flow288.5 M158.4 M247.1 M
Slightly volatile
Depreciation30 M28.5 M11.6 M
Slightly volatile
Capital Expenditures8.6 M9.1 M21.3 M
Slightly volatile
End Period Cash Flow309.7 M274.6 M266.4 M
Slightly volatile
Sale Purchase Of Stock87.8 M92.4 M161.3 M
Very volatile
Issuance Of Capital Stock288.6 M248.2 M538.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.885.1381208
Slightly volatile
Days Sales Outstanding153161230
Slightly volatile
Stock Based Compensation To Revenue0.630.65874.5504
Slightly volatile
Capex To Depreciation0.30.31752.5661
Slightly volatile
Payables Turnover1.721.81256.1944
Slightly volatile
Sales General And Administrative To Revenue6.413.674.9832
Pretty Stable
Research And Ddevelopement To Revenue5.45.683721.3315
Pretty Stable
Capex To Revenue0.290.3071.4991
Pretty Stable
Cash Per Share2.02.100611.9436
Very volatile
Days Payables Outstanding1912011.2 K
Pretty Stable
Intangibles To Total Assets0.02780.0260.0385
Slightly volatile
Current Ratio1.341.40767.9678
Slightly volatile
Receivables Turnover2.152.267410.1051
Pretty Stable
Graham Number8.338.769438.396
Pretty Stable
Debt To Equity0.0310.05570.0286
Slightly volatile
Capex Per Share0.07830.08250.4491
Pretty Stable
Revenue Per Share0.260.26860.704
Pretty Stable
Interest Debt Per Share0.150.14890.1963
Slightly volatile
Debt To Assets0.02020.03510.0193
Slightly volatile
Days Of Payables Outstanding1912011.2 K
Pretty Stable
Ebt Per Ebit1.080.86810.9872
Slightly volatile
Total Debt To Capitalization0.02950.05240.0274
Slightly volatile
Debt Equity Ratio0.0310.05570.0286
Slightly volatile
Quick Ratio1.231.29318.3313
Slightly volatile
Net Income Per E B T0.780.99940.9203
Slightly volatile
Cash Ratio1.051.10814.7866
Slightly volatile
Days Of Sales Outstanding153161230
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.851.03851.0483
Very volatile
Fixed Asset Turnover0.10.11050.5249
Slightly volatile
Debt Ratio0.02020.03510.0193
Slightly volatile
Price Sales Ratio4.885.1381208
Slightly volatile
Asset Turnover0.02820.04760.0343
Very volatile

Bluebird Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap318.1 M357.8 M389.6 M
Slightly volatile
Enterprise Value386.4 M380.2 M343.1 M
Pretty Stable

Bluebird Upcoming Events

3rd of April 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bluebird Bio Financial Statements

Bluebird Bio stakeholders use historical fundamental indicators, such as Bluebird Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bluebird Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bluebird Bio's assets and liabilities are reflected in the revenues and expenses on Bluebird Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bluebird bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.4 M1.3 M
Total Revenue29.5 M41.4 M
Cost Of Revenue33.5 M36.1 M
Stock Based Compensation To Revenue 0.66  0.63 
Sales General And Administrative To Revenue 3.67  6.41 
Research And Ddevelopement To Revenue 5.68  5.40 
Capex To Revenue 0.31  0.29 
Revenue Per Share 0.27  0.26 
Ebit Per Revenue(8.28)(8.69)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:
Check out the analysis of Bluebird Bio Correlation against competitors.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.80)
Revenue Per Share
0.357
Quarterly Revenue Growth
1.337
Return On Assets
(0.36)
Return On Equity
(1.87)
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.